Buyer for pharma detachment company in Western Europe

• Revenue: 2-50M EUR
• Employees: not decisive
• Location of the target: Western Europe
• Reason for acquisition: The company is a European pharma detachment group. It has a strategy for growing its operations in Western Europe via acquisitions, therefore the management is open to speaking to interested sellers
• #CFIE ITB102

The buyer is a large pharma detachment company looking for targets to acquire in Europe. It registers revenues of more than 80M Euro with an annual rate of profitability of more than 15%. Involved in the M&A projects is the M&A integration team formed by senior management professionals. The buyer has a very high appetite for acquisitions, it has a medium number of 10 acquisitions per year. It is continuously in acquisition mode and now is open for discussions with possible sellers. Target companies should activate in pharma detachment and should be located in Western Europe, preferably in Netherlands, France, Switzerland, Germany and Nordics. The target should also register revenues ranging from 2M to 50 M Euro or more and the number of employees could be between 30 and 500 FTEs. As possible synergies, the buyer can bring to the target specific tools, back-office functions and buying power.

The buyer company has several offices in European countries such as France, Germany, Belgium and Switzerland. This company has more than 20 years of experience in the market and came to employ more than 500 professional consultants and engineers that have experience in medical affairs, clinical research & development, cold chain management, data integrity, quality assurance, regulatory affairs, computer system validation, project management, operational excellence, etc. Since pharma industry is a very sensible sector that requires much attention for regulations, security, quality and specific parameters, the company has competent specialists that are able to assist the pharma clients in all important and needed processes, the company’s systems and industry expertise can produce progress and productivity. There are several methods of working, as it follows: the company can staff projects with its own experts, it can identify and recruit specialists to join the customer’s team or it can manage the whole project with its own team without any contribution from the client.

The company provides installation & operation & performance qualifications, verifies and validates internal processes, computer systems, clean rooms and equipment so that it is compliant with FDA, GMP and other regulations. Automated processes are validated by the company’s computer system validation (CSV) solution, the team formed by engineers and project managers has deep knowledge and expertise in the area of validation processes. The team can assist clients with: CSV support for required regulations, new technologies, data integrity; the execution of GAP and risk analyses, completing of validation documents (plans, protocols, etc.), implementation of validation tests, consultancy regarding best practices, etc. In quality affairs, the company’s specialists provide support in R&D, the production, the quality assurance and the quality control of medical drugs. Here can be mentioned consultancy and support in crucial elements such as auditing, compliance, quality management systems, quality analyses and procedural approaches. For pharma clients that operate with temperature-sensitive products, the company provides cold chain management solutions that ensure an optimum temperature control for all phases of product chain (production, transit, storage and distribution).

The buyer wants to acquire a company that operates in the same activity and has similar services such as:

• Pharma Consulting
• Project Management
• Business Process Outsourcing
• Recruitment

Target companies should have expertise in:

• CSV
• Medical Affairs
• Clinical Research & Development
• Verification & Qualification & Validation
• Quality Assurance & Control
• Data Integrity
• Training & Learning

• The buyer is a large pharma detachment company active in European market
• The company has decided to enlarge its activities in Western Europe
• The company is looking to buy another company with similar services and activities